Greenwich LifeSciences adds up to 10 UK sites
Greenwich LifeSciences (NASDAQ:GLSI) received UK regulatory approval to add an estimated 5–10 sites to its Phase III FLAMINGO-01 breast cancer trial.
Greenwich LifeSciences (NASDAQ:GLSI) received UK regulatory approval to add an estimated 5–10 sites to its Phase III FLAMINGO-01 breast cancer trial.
Otis Worldwide (NYSE:OTIS) reported second-quarter sales of $3.86 billion, up 7%, as Service growth offset weaker New Equipment profitability.
TE Connectivity (NYSE:TEL) reported record fiscal third-quarter sales of $5.16 billion, up 14% year over year and 12% organically.
Cal-Maine Foods (NASDAQ:CALM) reported $552.6 million in fourth-quarter sales and a $35.9 million loss, or $0.76 per share.
Repligen (NASDAQ:RGEN) agreed to acquire BioLife Solutions (NASDAQ:BLFS) in a cash-and-stock transaction valued at approximately $1.5 billion.
Joby Aviation (NYSE:JOBY) signed a multi-year agreement making Virgin Atlantic its exclusive UK airline partner for air taxi services.
EU regulators will formally outline subsidy concerns against JD.com (NASDAQ:JD) over its $2.5 billion bid for Ceconomy.
Alphabet (NASDAQ:GOOG) reported second-quarter revenue of $119.8 billion, up 24%, as Services and Cloud sales increased.
ServiceNow (NYSE:NOW) reported second-quarter subscription revenue of $3.88 billion, up 24.5%, as total revenue increased 24% to $3.99 billion.
Genenta (NASDAQ:GNTA) said Sòphia High Tech’s FY2025 sales rose 29.3% to €7.17 million, alongside increased operating profitability.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy